⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of hc1 and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
hc1
↗Indianapolis, USA
hc1 is a healthcare technology company specializing in lab intelligence. Founded in 2011, the company provides an AI-powered platform that transforms diagnostic, genomic, and medication data into actionable insights for health systems, laboratories, and health plans. Their solutions aim to improve patient care, streamline lab operations, and optimize financial performance by identifying real-time signals and risk factors within complex laboratory data.
The company has expanded its focus from clinical lab management to include life sciences and pharmaceutical applications, helping to match patient needs with optimal therapies. In 2024, hc1 acquired Accumen, a company focused on lab and hospital operational performance, to further strengthen its market position.
CLASSIFICATION
Company Type:Digital Health
Therapeutic Areas:-
Industry:Digital Health
Sub-Industry:Healthcare IT / Lab Intelligence
SIZE & FINANCIALS
Employees:51-200
Founded:2011
Ownership:private
Status:operating
FUNDING
Stage:Series B
Total Raised:$52.1M
Investors:Health Cloud Capital
0
CORPORATE STRUCTURE
Subsidiaries:Accumen
Key Partnerships:MMIT (Managed Markets Insights) - partnership to match patient needs with optimal therapies
COMPETITION
Position:Leader
Competitors:athenahealth, Electronic Care Corp, Infinitus
LEADERSHIP
Key Executives:
Brad Bostic - CEO and Founder
LINKS
Website:hc1.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with hc1. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.